MIM
IBB icon

Macroview Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Macroview Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-109
Closed -$15.9K – 289
2024
Q3 		$15.9K Buy
109
+7
+7% +$1.01K 0.02% 191
2024
Q2 		$14K Buy
102
+59
+137% +$7.88K 0.01% 202
2024
Q1 		$5.9K Buy
43
+37
+617% +$5.05K 0.01% 378
2023
Q4 		$816 Sell
6
-538
-99% -$65.6K ﹤0.01% 562
2023
Q3 		$66.5K Buy
544
+534
+5,340% +$67.9K 0.09% 103
2023
Q2 		$1.27K Hold
10
– – ﹤0.01% 414
2023
Q1 		$1.29K Sell
10
-188
-95% -$24.6K ﹤0.01% 375
2022
Q4 		$26K Buy
+198
New +$25.6K 0.04% 121
2019
Q3 		– Sell
-72
Closed -$8K – 308
2019
Q2 		$8K Hold
72
– – 0.02% 154
2019
Q1 		$8K Hold
72
– – 0.02% 157
2018
Q4 		$7K Hold
72
– – 0.02% 143
2018
Q3 		$9K Buy
+72
New +$8.48K 0.03% 129
2016
Q1 		– Sell
-600
Closed -$68K – 103
2015
Q4 		$68K Hold
600
– – 0.22% 34
2015
Q3 		$61K Hold
600
– – 0.11% 36
2015
Q2 		$74K Sell
600
-495
-45% -$59.3K 0.08% 35
2015
Q1 		$125K Hold
1,095
– – 0.12% 40
2014
Q4 		$111K Hold
1,095
– – 0.12% 43
2014
Q3 		$100K Sell
1,095
-300
-22% -$26.3K 0.13% 36
2014
Q2 		$120K Sell
1,395
-1,200
-46% -$94.5K 0.16% 35
2014
Q1 		$205K Buy
2,595
+45
+2% +$3.75K 0.31% 31
2013
Q4 		$193K Sell
2,550
-900
-26% -$63.9K 0.35% 29
2013
Q3 		$241K Sell
3,450
-2,100
-38% -$138K 0.42% 24
2013
Q2 		$322K Buy
+5,550
New +$321K 0.34% 16

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Macroview Investment Management's IBB Position: Q4 2024 in Review

Macroview Investment Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 109 shares — an estimated $15.9K sold.

Macroview Investment Management first reported a position in IBB in Q2 2013 and held it in 23 quarters. The position peaked at $322K in Q2 2013. 878 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Macroview Investment Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 109 iShares Biotechnology ETF shares in Q4 2024, an estimated $15.9K.
  • Macroview Investment Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 23 quarters.
  • Macroview Investment Management's iShares Biotechnology ETF position peaked at $322K in Q2 2013.
  • 878 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.